[
    [
        {
            "time": "",
            "original_text": "市值冲破1600亿港元!翰森制药领跑港股医药股，高市值背后有何难题待解？",
            "features": {
                "keywords": [
                    "市值",
                    "翰森制药",
                    "港股",
                    "医药股",
                    "高市值",
                    "难题"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "市值冲破1600亿港元!翰森制药领跑港股医药股，高市值背后有何难题待解？",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]